Pfizer Limited
PFIZER · Pharma · NSE
₹4,859
Current Market Price
Fair Value (DCF)
₹5,830
Margin of Safety
+20.0%
Updated 1d ago
YieldIQ Score
65/100
Piotroski F-Score
7/9
Economic Moat
Wide
Confidence
58%
ROE
18.2%
Debt/Equity
0.00
WACC
9.8%
Market Cap
₹0.22 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
23.6%
Return on capital employed
EV / EBITDA
18.8×
Enterprise multiple
Debt / EBITDA
0.1×
Leverage vs earnings
Interest Coverage
121.8×
EBIT covers interest
Current Ratio
6.17×
Short-term liquidity
Asset Turnover
0.54×
Revenue per ₹ of assets
Revenue CAGR (3Y)
0.8%
3-year revenue growth
Revenue CAGR (5Y)
2.1%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹4,859.4
Bear case
₹3,141.74
MoS -54.7%
Base case
₹5,830.41
MoS +16.7%
Bull case
₹7,105.36
MoS +31.6%
Ratio Trends
PFIZER · last 8 annual periods
ROE
18.2%
ROCE
25.1%
Operating Margin
—
Debt / Equity
0.03×
PE
122.3×
EV / EBITDA
16.8×
Historical Financials
PFIZER · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹2239 Cr | ₹2611 Cr | ₹2422 Cr | ₹2193 Cr | ₹2281 Cr | +0.5% |
| EBITDA | — | ₹898 Cr | ₹943 Cr | ₹824 Cr | ₹1085 Cr | +4.8% |
| EBIT | ₹684 Cr | ₹783 Cr | ₹167 Cr | ₹251 Cr | — | -22.2% |
| PAT | ₹498 Cr | ₹613 Cr | ₹624 Cr | ₹551 Cr | ₹768 Cr | +11.4% |
| EPS (diluted) | ₹108.77 | ₹133.89 | ₹28.34 | ₹22.33 | — | -32.7% |
| CFO | ₹427 Cr | ₹667 Cr | ₹356 Cr | ₹257 Cr | ₹660 Cr | +11.5% |
| CapEx | — | — | — | — | ₹-28.1 Cr | — |
| FCF | — | — | — | — | ₹632 Cr | +0.0% |
| Total Assets | — | ₹3901 Cr | ₹4001 Cr | ₹4229 Cr | ₹4911 Cr | +5.9% |
| Total Debt | — | — | ₹2.5 Cr | ₹2.5 Cr | ₹108 Cr | +156.6% |
| Shareholders' Equity | — | — | ₹3207 Cr | ₹3596 Cr | ₹4217 Cr | +7.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
PFIZER vs 1 closest peer by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| GLAXO GLAXO | — | — | Pending | 47.5% | — |
Click a ticker to view its fair-value analysis.
Dividend History
12 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹340.00/sh
Last payout
2025-07-09
₹165.00
Peak payout
₹320.00
Trailing yield
3.40%
Amounts parsed from NSE subject lines; percent-of-face-value declarations are not converted and shown as missing.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Pfizer Limited's current price is 4859.40, with a fair value of 5830.41 and a margin of safety of 20.0%. Its ROCE is 23.6% and ROE is 18....
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of PFIZER →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for PFIZER →
Compare
Head-to-head with peers
Compare PFIZER side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse PFIZERNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.